NIH-funded research NIH-funded research

Understanding how the environment affects the growth of intestinal organoids from stem cells

Official title: 4D controllable extracellular matrix properties to guide iPSC-derived intestinal organoid fate and form

Funded at Syracuse University · NIH-11059999 · Data updated 2026-11-12

This study is looking at how the supportive structure around cells, called the extracellular matrix, can help grow tiny models of the intestine from stem cells, which could lead to better ways to understand and treat intestinal diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSyracuse University
NIH-funded
Lab location1 site (Syracuse, United States)
Project startApril 1, 2024
Project endMarch 31, 2027
Funding year2025
Award (this year)$249,000
NIH project number5R00DK135907-03
Project IDNIH-11059999 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who may have conditions related to intestinal health or diseases.

Less likely to help

Patients with conditions unrelated to intestinal health or those under 21 years old may not benefit from this research.

What this research studies

This research investigates how the properties of the extracellular matrix (ECM) influence the development of intestinal organoids derived from induced pluripotent stem cells (iPSCs). By creating biomaterials that mimic the natural environment of the intestine, the study aims to better understand how these materials can affect cell behavior and organoid maturation. The approach involves manipulating the ECM properties to observe their impact on organoid growth and function, which could lead to more accurate models for studying human intestinal diseases. Patients may benefit from advancements in organoid technology that could improve disease modeling and treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to more effective models for studying intestinal diseases, ultimately improving treatment options for patients.

How similar studies have gone: Previous research has shown promise in using organoids for modeling diseases, indicating that this approach could yield significant advancements.

Where this research is happening

  • Syracuse University
    Syracuse, United States
    Active

Researchers

  • Principal investigator: Blatchley, Michael — Syracuse University
  • Study coordinator: Blatchley, Michael

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.